The store will not work correctly when cookies are disabled.
1-(butylamino)-3-(naphthalen-1-yloxy)propan-2-ol
ID: ALA3245763
Cas Number: 4618-24-0
PubChem CID: 199631
Max Phase: Preclinical
Molecular Formula: C17H23NO2
Molecular Weight: 273.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCNCC(O)COc1cccc2ccccc12
Standard InChI: InChI=1S/C17H23NO2/c1-2-3-11-18-12-15(19)13-20-17-10-6-8-14-7-4-5-9-16(14)17/h4-10,15,18-19H,2-3,11-13H2,1H3
Standard InChI Key: AITWWMQZEHPPKO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
1.0139 -12.7779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0127 -13.5933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7249 -14.0022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7231 -12.3690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4276 -12.7743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4284 -13.5933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1328 -14.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8452 -13.5936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8446 -12.7756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1355 -12.3682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1352 -11.5510 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8359 -11.1360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5504 -11.5536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2580 -11.1418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5536 -12.3691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9681 -11.5487 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6726 -11.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3827 -11.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0872 -11.1360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7973 -11.5429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 1 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.38 | Molecular Weight (Monoisotopic): 273.1729 | AlogP: 2.97 | #Rotatable Bonds: 8 |
Polar Surface Area: 41.49 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.76 | CX LogP: 3.13 | CX LogD: 0.83 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.73 | Np Likeness Score: -0.51 |
References
1. Rauls DO, Baker JK.. (1979) Relationship of nonspecific antiarrhythmic and negative inotropic activity with physicochemical parameters of propranolol analogues., 22 (1): [PMID:423187] [10.1021/jm00187a018] |